Zelah graduated from UCL in 2010 with a first class honours degree in Biomedical Sciences with a focus on neuroscience and pharmacology. She went on to complete her  PhD in neuroscience at UCL in autumn 2015 before spending a year as Head of Operations for an SME in London. Zelah joined Small Pharma in October 2016 where she headed the nonclinical development of Small Pharma’s first drug candidate for depression. 

Zelah now works across both the preclinical and clinical development programmes at Small Pharma. Her role includes assisting with experimental design and managing study execution.